<DOC>
	<DOCNO>NCT02529345</DOCNO>
	<brief_summary>The objective clinical investigation evaluate clinical outcome ( 12 month ) treatment mean stenting RoadSaver ( Terumo ) subject high risk carotid endarterectomy require carotid revascularization due significant extra-cranial carotid artery stenosis .</brief_summary>
	<brief_title>Clear-Road Trial , Investigating Efficacy RoadSaver Stent</brief_title>
	<detailed_description>It Prospective , multi-center , physician-sponsored clinical study . The objective clinical investigation evaluate clinical outcome ( 12 month ) treatment mean stenting RoadSaver ( Terumo ) subject high risk carotid endarterectomy require carotid revascularization due significant extra-cranial carotid artery stenosis .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>High risk carotid endarterectomy due anatomical comorbid condition either : neurological symptom ≥ 50 % stenosis via angiography , asymptomatic ≥ 80 % stenosis via angiography . 1 . Target lesion locate distal common carotid artery ( CCA ) , internal carotid artery ( ICA ) , carotid bifurcation . 2 . Arterial segment stented diameter 4mm 9mm 3 . Age ≥ 18 year . 4 . Life expectancy &gt; 12 month date index procedure . 5 . Provides sign , IRB ( Institutional Review Board ) / IEC ( Institutional Ethical Committee ) approve informed consent form prior participation . 6 . Willing able comply followup requirement . 1 . Contraindication percutaneous transluminal angioplasty ( PTA ) . 2 . Sever vascular tortuosity anatomy would preclude safe introduction guide catheter , sheath , embolic protection system stent system . 3 . Lesions ostium common carotid artery . 4 . Occlusion target vessel . 5 . Evidence intraluminal thrombus . 6 . Known sensitivity nickeltitanium . 7 . Known allergy heparin , aspirin anticoagulant/antiplatelet therapy , unable unwilling tolerate therapy . 8 . Uncorrectable bleeding disorder , refuse block transfusion . 9 . History prior lifethreatening contrast medium reaction . 10 . Previous stent placement target vessel . 11 . Evolving stroke intracranial haemorrhage . 12 . Previous intracranial haemorrhage brain surgery within past 12 month . 13 . Clinical condition make endovascular therapy impossible hazardous .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>